Evidence map›Paper›PMID 42579169›Full record

ArticleImmunologic research2026

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.

Bogusz Aksak-Wąs, Karolina Skonieczna-Żydecka, Danuta Cembrowska-Lech, Miłosz Parczewski, Rafał Hrynkiewicz, Filip Lewandowski, Karol Serwin, Kaja Mielczak, Mateusz Bruss, Franciszek Lenkiewicz and 1 more

Abstract read
In one paragraph

Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bogusz Aksak-WąsDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland. bogusz.aksak.was@pum.edu.pl.
Karolina Skonieczna-ŻydeckaDepartment of Biochemical Science, Pomeranian Medical University in, Szczecin, Szczecin, Poland. karolina.skonieczna.zydecka@pum.edu.pl.
Danuta Cembrowska-LechDepartment of Biochemical Science, Pomeranian Medical University in, Szczecin, Szczecin, Poland.
Miłosz ParczewskiDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland.
Rafał HrynkiewiczInstitute of Biology, University of Szczecin, Szczecin, Poland.
Filip LewandowskiInstitute of Biology, University of Szczecin, Szczecin, Poland.
Karol SerwinDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland.
Kaja MielczakDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland.
Mateusz BrussDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland.
Franciszek LenkiewiczDepartment of Infectious, Tropical Diseases and Acquired Immunodeficiency. Pomeranian Medical University in Szczecin, Szczecin, Poland.
Paulina Niedźwiedzka-RystwejInstitute of Biology, University of Szczecin, Szczecin, Poland.

Funding

Polish AIDS Society (PTN AIDS) The influence of immune depletion receptors PD-1 and PD-1 ligand on the immune reconsti-tution of PLWH.Polish National Science Centre (NCN) MINIATURA 7: DEC-2023/07/X/NZ6/00001
6 · The paper itself

Abstract

Chronic viral coinfections may contribute to persistent immune dysregulation in people with HIV, but their association with PD-1/PD-L1 expression remains uncertain. We analysed 100 people with HIV using available-case endpoint analyses and marker-specific paired baseline-to-follow-up analyses. Follow-up was scheduled at 12 months (allowable window, 9-15 months), and all participants had HIV RNA < 50 copies/mL at the endpoint. Baseline HBV contact, HCV status, and CMV IgG serostatus were evaluated in relation to PD-1 and PD-L1 expression on CD4⁺ T cells and CD19⁺ B cells and exploratory composite checkpoint-expression indices. HBV contact and CMV IgG serostatus were not associated with reproducible differences. The global comparison of longitudinal CD4⁺ T-cell PD-L1 change across HCV groups did not remain significant after false-discovery-rate correction; an exploratory pairwise comparison suggested a greater increase in participants with baseline HCV RNA positivity. Overall, the HCV-related pattern was hypothesis-generating and requires prospective validation.

Indexed as

B7-H1 AntigenCD4-Positive T-LymphocytesCoinfectionCytomegalovirus InfectionsHepacivirusHepatitis CHIV-1HIV InfectionsAdultBiomarkersCytomegalovirusFemaleHumansMaleMiddle AgedProgrammed Cell Death 1 ReceptorB7-H1 AntigenBiomarkersCD274 protein, humanPDCD1 protein, humanProgrammed Cell Death 1 ReceptorCheckpoint-marker expressionCytomegalovirusHepatitis C virusHIVPD-1/PD-L1

Identifiers

PMID42579169
PMCPMC13461818

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.